# Ginkgo Bioworks Holdings, Inc. (DNA): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/dna for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NYSE · Trading currency: USD

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $9.99 USD |
| Market Cap | $672.7M |
| P/E (TTM) | — |
| EPS (TTM) | −$5.01 |
| 52-Week Range | $5.37 – $18.22 |
| Dividend Yield (TTM) | — |

## Dividend

DNA has no dividend payment history in our records.

## Frequently Asked Questions

### What does Ginkgo Bioworks Holdings, Inc. do?

Ginkgo Bioworks Holdings, Inc. (DNA) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is DNA's market cap?

Ginkgo Bioworks Holdings, Inc. (DNA) has a market capitalization of approximately $672.7 million, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does DNA pay a dividend?

No, Ginkgo Bioworks Holdings, Inc. (DNA) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is DNA profitable?

Ginkgo Bioworks Holdings, Inc. (DNA) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has DNA ever paid a dividend?

No. Dividend Data's records show no dividend payments from Ginkgo Bioworks Holdings, Inc. (DNA). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/dna
- Dividend history & safety: https://www.dividenddata.com/stocks/dna/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/dna/earnings
- Financial statements: https://www.dividenddata.com/stocks/dna/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/dna/valuation
- Peer comparison: https://www.dividenddata.com/stocks/dna/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.